FDA 483 - Winder Laboratories, LLC - February 03, 2026

A concise summary of the FDA 483 document cannot be generated as the document content was not provided. To fulfill the request, please supply the text from the specified pages (3 through 9) of the FDA 483, including details on the company name, inspection dates, identified violations, relevant regulatory framework, and any required actions.